Overview

Pseudodrynaria Coronana (Wall) Ching

Status:
Completed

Trial end date:
2001-01-01

Target enrollment:

Participant gender:

Summary

The Study to evaluate the clinical effect of "Gusuibu" lasts for 3 years. It aims to evaluate its effect on bone density of postmenopausal osteoporosis. Besides, its effects on the liver, kidney and the hematological influence will be evaluated, too.

Phase:

Phase 1

Details

Lead Sponsor:

National Taiwan University Hospital

Collaborator:

Sheng Chang Pharmaceutical